Artificial Intelligence Enhanced ECG to Detect Cardiac Amyloidosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The purpose of this study is to assess a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis of cardiac amyloidosis (CA).
Epistemonikos ID: b17c3f0e3e7bbefd5ca30eb0e32657d7f6bbca5d
First added on: May 13, 2024